MD Anderson, Theraclone Sciences form OncoResponse
OncoResponse, an immuno-oncology antibody discovery company, has been launched jointly by The University of Texas MD Anderson Cancer Center and Theraclone Sciences.
Source: M. D. Anderson Cancer Center - News Releases - Category: Cancer & Oncology Source Type: news